| abstract |
The present invention relates to the surprising discovery that the combination of several agents, each well known for its established role in treatinf cancer, inflammation, hemostasis, bone resorption or serving as a solubilizing vehicle, results in a synergistic anti-cancer composition. Furthermore, the combination of at least three agents allows the cytotoxic agent, such as cyclophosphamide, to be used at a lower dosage than when administered alone. One predidted consequence of this treatment, therefore, is a highly desirable reduction in toxic side effects due to the cytotoxic agent. |